Officer sold ~$30K of Corcept Therapeutics
Scheduled in advanceLoading…
Traded Aug 18, 2026 · Filed Aug 21, 2026
A board member of Corcept Therapeutics sold $585K of Corcept Therapeutics shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$585,478
Shares × reported transaction price
20 days after results of Jul 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −6.8% | +0.5% | −7.3% |
| 30 days | −6.9% | +1.0% | −8.0% |
Past results only. Not a forecast.
Officer sold ~$30K of Corcept Therapeutics
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.